Back to news

Periscope Equity Announces the Sale of its Portfolio Company, MicroMass Communications, Inc. to UDG Healthcare PLC

September 13, 2017

Chicago, IL – September 15, 2017. Headquartered in Cary, NC, MicroMass is an award-winning healthcare communications agency with unique expertise in changing patient and provider behavior. MicroMass builds custom marketing programs that help patients with chronic conditions, such as cancer or rare diseases to better engage in their own care and help providers generate better outcome in a value-based healthcare environment.

Headquartered in Cary, NC, MicroMass is an award-winning healthcare communications agency with unique expertise in changing patient and provider behavior. MicroMass builds custom marketing programs that help patients with chronic conditions, such as cancer or rare diseases to better engage in their own care and help providers generate better outcome in a value-based healthcare environment.

In December 2015, Periscope Equity acquired MicroMass and merged the company with Strategic Pharma Solutions, another portfolio company Periscope had acquired a year earlier. These two companies matched Periscope Equity’s investment criteria, leveraging the firm’s extensive experience in scaling data and technology companies within the healthcare and marketing services sectors.

“Through the merger of MicroMass and SPS, we set out to create one of the largest independent, full-service, multi-channel healthcare marketing and medical communications companies,” said Steve Jarmel, partner, Periscope Equity. “We achieved our goals by forging a collaborative partnership with the company’s talented management team, rapidly growing the business and delivering an excellent return to our investors.”

“We could not have chosen a better partner than Periscope as our investor,” said Alyson Connor, President of MicroMass. “Our close working partnership with the Periscope team was invaluable from the initial merger integration, to the execution of our strategic plan and ultimate sale to UDG. The entire MicroMass team is thrilled to join an industry leader like UDG and continue serving our clients with a broader spectrum of products and services.”

About MicroMass

MicroMass is a leading marketing agency focused on applying evidence-based behavior change strategies to create real-world solutions that optimize patient health outcomes. With expertise in human health behavior, MicroMass builds fundamentally different marketing programs that help patients with chronic conditions, cancer, and rare diseases build the confidence and the skills they need to better engage in their care.